Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ondřej Slanař, Karolína Hronová, Olga Bartošová & Martin Šíma. (2021) Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics. Expert Opinion on Drug Metabolism & Toxicology 17:3, pages 307-321.
Read now
Read now
Sonam Tulsyan, Rama Devi Mittal & Balraj Mittal. (2016) The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment. Pharmacogenomics and Personalized Medicine 9, pages 47-58.
Read now
Read now
Insee Sensorn, Chonlaphat Sukasem, Ekaphop Sirachainan, Montri Chamnanphon, Ekawat Pasomsub, Narumol Trachu, Porntip Supavilai, Darawan Pinthong & Sansanee Wongwaisayawan. (2016) ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen. OncoTargets and Therapy 9, pages 2121-2129.
Read now
Read now
Wanaporn Charoenchokthavee, Duangchit Panomvana, Virote Sriuranpong & Nutthada Areepium. (2016) Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment. Breast Cancer: Targets and Therapy 8, pages 149-155.
Read now
Read now
Articles from other publishers (13)
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, Kamonpan Sanachai, Maliheh Ershadian & Chonlaphat Sukasem. (2022) Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Frontiers in Pharmacology 13.
Crossref
Crossref
Carmen Wing Han Chan, Caixia Li, Eleven Jinnan Xiao, Minjie Li, Patrick Gladson McLeywick Phiri, Tingting Yan & Judy Yuet Wa Chan. (2022) Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis. Expert Reviews in Molecular Medicine 24.
Crossref
Crossref
Carla Miranda, Macarena Galleguillos, Roberto Torres, Karla Tardón, Dante D. Cáceres, Kuen Lee, María A. Redal, Nelson M. Varela & Luis A. Quiñones. (2021) Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. Frontiers in Pharmacology 12.
Crossref
Crossref
Tingyu Wang, Yitian Zhou & Guosheng Cao. (2021) Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes. European Journal of Clinical Pharmacology 77:8, pages 1095-1111.
Crossref
Crossref
Thomas Helland, Sarah Alsomairy, Chenchia Lin, Håvard Søiland, Gunnar Mellgren & Daniel Louis Hertz. (2021) Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer. Journal of Personalized Medicine 11:3, pages 201.
Crossref
Crossref
Qingyang Xiao, Yitian Zhou & Volker M Lauschke. (2020) Impact of variants in ATP-binding cassette transporters on breast cancer treatment. Pharmacogenomics 21:18, pages 1299-1310.
Crossref
Crossref
Viktor Hlaváč, Petr Holý & Pavel Souček. (2020) Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450. Journal of Personalized Medicine 10:3, pages 108.
Crossref
Crossref
Palden Wangyel Dorji, Gyem Tshering & Kesara Na‐Bangchang. (2019) CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South‐East and East Asian populations: A systematic review. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
Ahmad Aizat Abdul Aziz, Md Salzihan Md Salleh, Ibtisam Mohamad, Venkata Murali Krishna Bhavaraju, Maya Mazuwin Yahya, Andee Dzulkarnaen Zakaria, Siew Hua Gan & Ravindran Ankathil. (2018) Genotypes and haplotypes of ABCB1 contribute to TAC chemotherapy response in Malaysian triple negative breast cancer patients. Meta Gene 16, pages 21-27.
Crossref
Crossref
Deirdre P. Cronin-Fenton & Per Damkier. 2018. Pharmacogenetics. Pharmacogenetics
65
91
.
A. B. Sanchez Spitman, D. J. A. R. Moes, H. Gelderblom, V. O. Dezentje, J.J. Swen & H. J. Guchelaar. (2017) Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism. European Journal of Clinical Pharmacology 73:12, pages 1589-1598.
Crossref
Crossref
Wei Xiong, Jiajia Zhao, Ling Wang & Xuehua Jiang. (2017) UPLC-MS/MS method for the determination of tobacco-specific biomarker NNAL, tamoxifen and its main metabolites in rat plasma. Biomedical Chromatography 31:6, pages e3890.
Crossref
Crossref
Massimiliano Cocca, Davide Bedognetti, Martina La Bianca, Paolo Gasparini & Giorgia Girotto. (2016) Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations. Journal of Translational Medicine 14:1.
Crossref
Crossref